CID 3039160

Morpholine, 4-((4-(tetrahydro-2,4,6-trioxo-1(2h)-pyrimidinyl)-1-piperazinyl)acetyl)-

Structural Information

Molecular Formula
C14H21N5O5
SMILES
C1CN(CCN1CC(=O)N2CCOCC2)N3C(=O)CC(=O)NC3=O
InChI
InChI=1S/C14H21N5O5/c20-11-9-12(21)19(14(23)15-11)18-3-1-16(2-4-18)10-13(22)17-5-7-24-8-6-17/h1-10H2,(H,15,20,23)
InChIKey
NQRKNRQXRNBZBC-UHFFFAOYSA-N
Compound name
1-[4-(2-morpholin-4-yl-2-oxoethyl)piperazin-1-yl]-1,3-diazinane-2,4,6-trione
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

339.15427 Da
Monoisotopic Mass

-1.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 340.16155 184.2
[M+Na]+ 362.14349 186.6
[M-H]- 338.14699 184.3
[M+NH4]+ 357.18809 187.2
[M+K]+ 378.11743 183.7
[M+H-H2O]+ 322.15153 171.9
[M+HCOO]- 384.15247 188.1
[M+CH3COO]- 398.16812 206.7
[M+Na-2H]- 360.12894 181.3
[M]+ 339.15372 174.4
[M]- 339.15482 174.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.